Bio-Rad Laboratories, Inc. (BIO) quarterly cash flow statement — complete operating, investing & financing history
Bio-Rad Laboratories, Inc. (BIO) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | 96.4M | 98.7M | 108.1M | 164.9M | 120.9M | 116.5M | 129.9M | 124.15M | 163.61M | 97.65M | 69.79M | 81.05M | 97.71M | 98.07M | 98.12M | 90.42M | 11.03M | 53.27M | 50.49M | 157.92M |
| Operating CF Margin % | 14.69% | 15.16% | 18.26% | 23.79% | 18.51% | 17.88% | 22.19% | 18.6% | 25.18% | 15.29% | 11.43% | 11.9% | 15.46% | 14.4% | 14.5% | 12.38% | 1.62% | 7.71% | 7.21% | 21.55% |
| Operating CF Growth % | -20.26% | -15.28% | -16.78% | 32.82% | -26.1% | 19.31% | 86.12% | 53.19% | 67.44% | -0.43% | -28.87% | -10.37% | 786.11% | 84.1% | 94.32% | -42.74% | -95.21% | -65.55% | -55.55% | -44.54% |
| Net Income | 458.6M | -13.3M | -527.1M | 720M | -341.9M | -120.1M | 64M | -715.8M | 653.2M | -2.17B | 383.9M | 349.7M | 106.3M | -1.16B | 69M | 833.5M | -162.8M | -925.2M | -3.37B | -1.57B |
| Depreciation & Amortization | 41.2M | 0 | 40.9M | 42.5M | 44.2M | 40.6M | 38.1M | 49.3M | 38.9M | 36.4M | 37.1M | 37.2M | 37.3M | 35.8M | 35.6M | 40M | 34.3M | 34.1M | 33.4M | 33.7M |
| Stock-Based Compensation | 15.5M | 0 | 15M | 15.9M | 14.9M | -15.3M | 15.3M | 16.4M | 15.6M | 15M | 15.3M | 16.2M | 15.9M | 12.6M | 16.6M | 18.1M | 15.7M | 13.6M | 13.5M | 15M |
| Deferred Taxes | 117.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -520.7M | 109.4M | 747.8M | -867.6M | 506.1M | 254.9M | -31.1M | 717.3M | -764.79M | 2.89B | -420.51M | -313.85M | -59.29M | 1.59B | 17.22M | -949.88M | 296.23M | 1.34B | 4.55B | 2.16B |
| Working Capital Changes | -16M | 2.6M | -168.5M | 254.1M | -102.4M | -43.6M | 43.6M | 56.95M | 220.7M | -679.5M | 54M | -8.2M | -2.5M | -381.8M | -40.3M | 148.7M | -172.4M | -409.8M | -1.17B | -475.8M |
| Change in Receivables | 18.8M | -30.8M | 30.8M | 3.9M | 4.2M | -37.2M | 37.2M | -9.4M | -7.4M | -4.4M | 37.4M | -20.2M | 26.4M | 6.6M | -1.4M | -42.9M | 1.3M | 1M | -46.8M | -9.6M |
| Change in Inventory | -200K | 29.9M | -29.9M | 51.6M | 13.6M | 17.9M | -17.9M | 24.5M | 15.2M | -22.4M | -8.8M | 15.4M | -6.4M | -25.2M | -30.1M | -8.2M | -48.3M | -66.8M | -35.5M | 17.9M |
| Change in Payables | 17.5M | -9.6M | 9.6M | -1.3M | -33.3M | -29.8M | 29.8M | -16.5M | 2.2M | 17.8M | -44.4M | 20.6M | -37.7M | -42.9M | 8.2M | -24.5M | -26.6M | -4.2M | -38.9M | 47.5M |
| Cash from Investing | -145.9M | -66.7M | -93.2M | -34.2M | -43M | -115.4M | 2.9M | -30.54M | -55.64M | -30.93M | -43.09M | 72.2M | -9.5M | 27.98M | -70.47M | -69.31M | -88.42M | -144.48M | -916.14M | -554.48M |
| Capital Expenditures | -31.2M | -32M | -30M | -45.8M | -31.7M | -45.7M | -34.4M | -42.91M | -40.23M | -42.28M | -40.18M | -42.24M | -44.07M | -34.64M | -35.73M | -45.56M | -27.57M | -17.33M | -33.08M | -43.24M |
| CapEx % of Revenue | 4.75% | 4.92% | 5.07% | 6.61% | 4.85% | 7.01% | 5.88% | 6.43% | 6.19% | 6.62% | 6.58% | 6.2% | 6.97% | 5.09% | 5.28% | 6.24% | 4.05% | 2.51% | 4.72% | 5.9% |
| Acquisitions | 0 | -100K | 100K | 0 | -1.8M | -216.6M | 0 | 0 | 0 | 0 | 0 | 2.5M | 0 | 0 | 0 | 0 | -100.75M | 0 | 0 | -125.52M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 1.1M | 0 | 793.6M | 0 | 0 | 0 | -39K | -23.35M | 66K | 26K | 107K | 65K | 39K | 0 | -1.33M | 6K | 1.47M | 0 | 0 |
| Cash from Financing | -1.6M | -27.9M | -44M | 3.3M | -52.5M | -136.3M | -97.7M | -26.25M | -95.99M | -96.59M | 21K | -200.62M | -26.6M | -202.74M | 4.31M | -86.62M | -8.77M | -121.33M | 1.19B | 4.63M |
| Debt Issued (Net) | -100K | -300K | -100K | -200K | -300K | -200K | -100K | -41K | -123K | -118K | -118K | -118K | -118K | -116K | -115K | -143K | -113K | -150K | 1.19B | -1.38M |
| Equity Issued (Net) | 3.6M | 44.4M | -44.4M | 3.9M | -50M | -136M | -101.9M | -14K | -97.84M | -101M | -4.75M | -200M | -21.32M | -207.41M | 0 | -90.68M | 0 | -125M | 0 | 0 |
| Dividends Paid | 0 | -15.7M | -33.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -31.5M | -47.8M | 0 | -53.4M | -140.2M | -101.9M | -14K | -97.84M | -101M | -4.75M | -200M | -21.32M | -207.41M | 0 | -90.68M | 0 | -125M | 0 | 0 |
| Other Financing | -5.1M | -56.3M | 33.8M | -400K | -2.2M | -100K | 4.3M | -26.19M | 1.97M | 4.53M | 4.89M | -502K | -5.16M | 4.79M | 4.42M | 4.2M | -8.66M | 3.82M | 4.18M | 6.01M |
| Net Change in Cash | -51.7M | 9.5M | -23.2M | 132M | 26.5M | -151.4M | 33.3M | 77.61M | 4.47M | -26.04M | 29.38M | -53.95M | 67.83M | -74.02M | 29.96M | -83.7M | -78.66M | -205.75M | 331.52M | -393.39M |
| Free Cash Flow | 65.2M | 66.7M | 78.1M | 119.1M | 89.2M | 70.8M | 95.5M | 81.25M | 99.97M | 55.37M | 29.62M | 38.8M | 53.64M | 63.43M | 62.39M | 43.49M | -16.55M | 35.94M | 17.42M | 114.68M |
| FCF Margin % | 9.93% | 10.25% | 13.19% | 17.18% | 13.66% | 10.87% | 16.31% | 12.17% | 15.39% | 8.67% | 4.85% | 5.7% | 8.49% | 9.31% | 9.22% | 5.95% | -2.43% | 5.2% | 2.49% | 15.65% |
| FCF Growth % | -26.91% | -5.79% | -18.22% | 46.59% | -10.77% | 27.88% | 222.46% | 109.39% | 86.37% | -12.71% | -52.53% | -10.77% | 424.15% | 76.5% | 258.26% | -62.08% | -108.45% | -72.62% | -81.48% | -53.3% |
| FCF per Share | 2.42 | 2.49 | 2.90 | 4.41 | 3.31 | 2.60 | 3.42 | 2.90 | 3.57 | 1.95 | 1.04 | 1.35 | 1.84 | 2.16 | 2.10 | 1.46 | -0.56 | 1.21 | 0.58 | 3.83 |
| FCF Conversion (FCF/Net Income) | 0.21x | 0.27x | -0.21x | 0.23x | -0.35x | 0.37x | 2.03x | -0.17x | 0.25x | -0.05x | 0.18x | 0.23x | 0.92x | -0.08x | 1.42x | 0.11x | -0.07x | -0.06x | -0.01x | -0.10x |
| Interest Paid | 22.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 16.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |